default author photo

Shiqing Chen

3D Medicines, Inc. - Medical Affairs

SCHOLARLY PAPERS

2

DOWNLOADS

148

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Development and Validation of Postoperative Circulating Tumor DNA Combined with Clinicopathological Risk Factors for Recurrence Prediction in Patients with Stages I-III Colorectal Cancer

Number of pages: 27 Posted: 20 Sep 2022
Zhaoya Gao, Dandan Huang, Hui Chen, Yong Yang, Ke An, Changmin Ding, Zheping Yuan, Zhichao Zhai, Pengfei Niu, Qingkun Gao, Jinping Cai, Qingmin Zeng, Yanzhao Wang, Yuming Hong, Wanshui Rong, Wensheng Huang, Fuming Lei, Xiaodong Wang, Shiqing Chen, Xiaochen Zhao, Yuezong Bai and Jin Gu
Peking University - Department of Gastrointestinal Surgery III, Peking University - Department of Oncology, 3D Medicines, Inc. - Medical Affairs, Peking University - Department of Gastrointestinal Surgery III, Peking University - Department of Gastrointestinal Surgery III, Peking University - Department of Gastrointestinal Surgery III, 3D Medicines, Inc. - Medical Affairs, Peking University - Department of Gastrointestinal Surgery III, Peking University - Department of Gastrointestinal Surgery III, Peking University - Department of Gastrointestinal Surgery III, 3D Medicines, Inc. - Medical Affairs, Peking University - Department of Gastrointestinal Surgery III, Peking University - Department of Gastrointestinal Surgery III, Peking University - Department of Gastrointestinal Surgery III, Peking University - Department of Gastrointestinal Surgery III, Peking University - Department of Gastrointestinal Surgery III, Peking University - Department of Gastrointestinal Surgery III, Peking University - Department of Oncology, 3D Medicines, Inc. - Medical Affairs, 3D Medicines, Inc. - Medical Affairs, 3D Medicines, Inc. - Medical Affairs and Peking University - Department of Gastrointestinal Surgery III
Downloads 84 (777,583)

Abstract:

Loading...

colorectal cancer, circulating tumor DNA, clinicopathological risk factors, recurrence

2.

The Efficacy and Plasma ctDNA as a Biomarker of Dual PD-1 and HER2 Blockade in HER2-Positive Gastric or Gastroesophageal Junction Cancers

Number of pages: 25 Posted: 10 Aug 2022
Xiaoyi Chong, Yuezong Bai, Hua Liu, Zhengqing Yan, Lin Cong, Jifang Gong, Yakun Wang, Hui Chen, Jinping Cai, Shiqing Chen, Xiaochen Zhao, Cheng Zhang and Xiaotian Zhang
Peking University - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), 3D Medicines, Inc. - Medical Affairs, Peking University - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), 3D Medicines, Inc. - Medical Affairs, 3D Medicines, Inc. - Medical Affairs, 3D Medicines, Inc. - Medical Affairs, 3D Medicines, Inc. - Medical Affairs, Peking University - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing) and Peking University - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing)
Downloads 64 (933,592)

Abstract:

Loading...

circulating tumor DNA, HER2 amplification, gastric or gastroesophageal junction cancers, trastuzumab, anti-PD-1 immunotherapy